[go: up one dir, main page]

WO2004094589A3 - Secreted proteins - Google Patents

Secreted proteins Download PDF

Info

Publication number
WO2004094589A3
WO2004094589A3 PCT/US2004/010077 US2004010077W WO2004094589A3 WO 2004094589 A3 WO2004094589 A3 WO 2004094589A3 US 2004010077 W US2004010077 W US 2004010077W WO 2004094589 A3 WO2004094589 A3 WO 2004094589A3
Authority
WO
WIPO (PCT)
Prior art keywords
secp
secreted proteins
polynucleotides
agonists
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/010077
Other languages
French (fr)
Other versions
WO2004094589A2 (en
Inventor
Anita Swarnakar
Thomas W Richardson
Jayalaxmi Ramkumar
Soo Yeun Lee
Shanya D Becha
Vicki S Elliott
Narinder K Chawla
Kristin D Favero
Jonathan T Wang
Mariah R Baughn
David Chien
Pei Jin
Amy D Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of WO2004094589A2 publication Critical patent/WO2004094589A2/en
Publication of WO2004094589A3 publication Critical patent/WO2004094589A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human secreted proteins (SECP) and polynucleotides which identify and encode SECP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
PCT/US2004/010077 2003-04-18 2004-04-01 Secreted proteins Ceased WO2004094589A2 (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US46398903P 2003-04-18 2003-04-18
US60/463,989 2003-04-18
US46748803P 2003-04-30 2003-04-30
US60/467,488 2003-04-30
US47071403P 2003-05-14 2003-05-14
US60/470,714 2003-05-14
US47503403P 2003-05-30 2003-05-30
US60/475,034 2003-05-30
US48345103P 2003-06-26 2003-06-26
US60/483,451 2003-06-26
US49181803P 2003-08-01 2003-08-01
US60/491,818 2003-08-01

Publications (2)

Publication Number Publication Date
WO2004094589A2 WO2004094589A2 (en) 2004-11-04
WO2004094589A3 true WO2004094589A3 (en) 2005-03-17

Family

ID=33314580

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/010077 Ceased WO2004094589A2 (en) 2003-04-18 2004-04-01 Secreted proteins

Country Status (1)

Country Link
WO (1) WO2004094589A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928187B2 (en) 2005-03-07 2011-04-19 Austria Wirtschaftsservice Gesellschaft Mit Beschrankter Haftung Neuropeptide alarin

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1590437A4 (en) 2003-01-24 2008-06-18 Agensys Inc Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
WO2013003801A2 (en) 2011-06-29 2013-01-03 The Trustees Of Columbia University In The City Of New York Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction
KR102092225B1 (en) * 2014-04-30 2020-03-23 주식회사 엘지화학 A protein secretory factor with a high secretory efficiency and a expression vector comprising the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025197A (en) * 1997-03-19 2000-02-15 Zymogenetics, Inc. Secreted salivary zsig32 polypeptides
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025197A (en) * 1997-03-19 2000-02-15 Zymogenetics, Inc. Secreted salivary zsig32 polypeptides
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928187B2 (en) 2005-03-07 2011-04-19 Austria Wirtschaftsservice Gesellschaft Mit Beschrankter Haftung Neuropeptide alarin

Also Published As

Publication number Publication date
WO2004094589A2 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2002038602A3 (en) Secreted proteins
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2001098353A3 (en) Secreted proteins
WO2003029437A3 (en) Secreted proteins
WO2003048305A3 (en) Receptors and membrane-associated proteins
WO2002048337A3 (en) Secreted human proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2001079291A3 (en) Secreted proteins
WO2003004615A3 (en) Secreted proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2003068943A3 (en) Secreted proteins
WO2002086069A3 (en) Secreted proteins
WO2002070669A3 (en) Secreted proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2002026982A3 (en) Secreted human proteins
WO2003087300A3 (en) Secreted proteins
WO2004100774A3 (en) Receptors and membrane-associated proteins
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003016506A3 (en) Secreted proteins
WO2002079441A3 (en) Secreted proteins
WO2004094589A3 (en) Secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase